Issue in Progress

J Psychiatry Neurosci 2021 July-August;46(4)

Research Papers

Elevated body weight modulates subcortical volume change and associated clinical response following electroconvulsive therapy
N. Opel, K.L. Narr, C. Abbott, M. Argyelan, R. Espinoza, L. Emsell, F. Bouckaert, P. Sienaert, M. Vandenbulcke, P. Nordanskog, J. Repple, E. Kavakbasi, M.B. Jorgensen, O.B. Paulson, L.G. Hanson, A. Dols, E. van Exel, M.L. Oudega, A. Takamiya, T. Kishimoto, O.T. Ousdal, J. Haavik, Å. Hammar, K.J. Oedegaard, U. Kessler, H. Bartsch, A.M. Dale, B.T. Baune, U. Dannlowski, L. Oltedal, R. Redlich

CCR5-Δ32 polymorphism: a possible protective factor for post-stroke depressive symptoms
O. Tene, H. Hallevi, J. Molad, S. Usher, E. Seyman, N.M. Bornstein, S. Shenhar-Tsarfaty, E. Ben Assayag

Genetic risk for bipolar disorder and schizophrenia predicts structure and function of the ventromedial prefrontal cortex
C. Abé, P. Petrovic, W. Ossler, W.H. Thompson, B. Liberg, J. Song, S.E. Bergen, C.M. Sellgren, P. Fransson, M. Ingvar, M. Landén

Alterations of cellular aging markers in obsessive–compulsive disorder: mitochondrial DNA copy number and telomere length
J.I. Kang, C.I. Park, J. Lin, S.T. Kim, H.W. Kim, S.J. Kim

Blockade of corticotropin-releasing factor receptor 1 in the central amygdala prevents cocaine-seeking behaviour induced by orexin-A administered to the posterior paraventricular nucleus of the thalamus in male rats
A. Matzeu, R. Martin-Fardon

Psychopharmacology for the Clinician

Use of MAOIs in severe treatment-resistant depression: back to the old school
J. Cookey

Oculogyric crisis: a rare type of dystonia
S. Boi, C. Garcia-Malo, C.I. Rodríguez